actively expressed in circulating neutrophils are those which are either subject to rapid turnover (i.e. those of the contractile machinery and membrane receptors) or those whose rate of biosynthesis needs to be increased during inflammation. It does not appear that mature cells actively synthesize, or upregulate during 'priming', those components normally present in high concentrations and/or not subject to turnover in non-activated cells (i.e. granule enzymes or the components of the NADPH oxidase). These up-regulated proteins appear to play an important role in the function of these cells during an acute inflammatory response and further work is clearly necessary to characterize these proteins and identify their biological functions.
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There is now considerable evidence that the capsular polysaccharides on the surface of both Gram-negative and Grampositive bacteria play a key role in virulence by conferring serum resistance and inhibiting phagocytosis by polymorphonuclear leucocytes (PMNL) (Peterson et ul., 1978; Horwitz & Silverstein, 1980; Kim et ul., 1986; Allen er a/., 1987) . In this regard, the best studied examples are the Gram-positive bacteria Staphylococcus uureus and Streptococcus pneirrnoniue. Studies on S. uureus have shown that encapsulated strains have increased virulence compared with their unencapsulated variants (Melly el al., 1074) . Encapsulated strains are more resistant to serum killing and serummediated opsonization and phagocytosis by PMNL (Peterson et ul.. 1978) . This is an important initial defence mechanism in the non-immune host. The resistance of S . aureus to complement-mediated opsonization is not due to capsule-mediated inhibition of the alternative pathway of complement activation (Verbrugh et ul., 1079) . Rather, encapsulated S . urrreus do bind opsonically active C3b, but underneath the capsule; thus bound C3b is masked from C3b receptors on the PMNL cell surface (Wilkinson et ul., 1979) . As a result there is only a poor correlation between the total amount of C3b deposited and the effective opsonization of S. aureus. Recent studies (Verbrugh et d., 1982; Karakawa et ul., 1988) have shown that specific capsular antibodies play a crucial role in the phagocytosis of S . airreus. Indeed it is likely that phagocytosis of encapsulated S . uureus occurs by opsonization by capsule-specific antibodies and uptake by PMNL via Fc receptors. The presence of specific capsular antibodies will cause activation of the classical pathway complement in the capsule, thereby increasing opsonization and allowing C 3b-mediated phagocytosis.
A primary virulence determinant of S. prreumorriue is the capsule. Virulent encapsulated S. pneumoniue are resistant *To whom correspondence should be addressed. Abbreviations used: PMNL. polymorphonuclear leucocyte; LPS, lipopolysaccharide; Mab. monoclonal antibody.
to the bacteriocidal action of complement and in the absence of specific antibodies are poorly phagocytosed and killed by PMNL (Winkelstein et ul., 1976) . When encapsulated S. pneumoniae activate complement by the alternative pathway, the capsule plays no role in this activation (Winkelstein eta/., 1976) . As for S. aureus, C3b molecules generated by the alternative pathway are deposited on the pneumococcal cell wall beneath the capsule (Winkelstein et al., 1980) , resulting in reduced opsonic potency and a reduction in C3b-mediated phagocytosis by PMNL. The presence of specific capsular antibodies causes C 3b deposition on the pneumococcal capsule by classical pathway activation of complement, maximizing phagocytosis of the pneumococcus via both Fc and C3b receptors on the PMNL. The inaccessibility of C3b deposited on the pneumococcal cell wall can be demonstrated by immune adherence. Human erythrocytes possessing a C3b receptor on their surface can be agglutinated by exposed C 3b. Pneumococci opsonized in non-immune serum fail to agglutinate such cells, while pneumococci opsonized in the presence of capsule-specific antibodies cause immune adherence (Brown et al., 1982) . Clearly in both S. aureus and S. pneumoniae, the capsule plays a key role in non-immune serum in masking the cell-wall-bound C3b from the appropriate C3b receptor on the PMNL.
The presence of a capsule has been implicated in the virulence of many Gram-negative bacteria (Makela et al., 1080; Robbins et al., 1980) . In contrast to the cell surface of Grampositive bacteria, the complex nature of the cell envelope of Gram-negative bacteria, including the presence of lipopolysaccharide (LPS) and outer membrane and surface proteins, in addition to capsular polysaccharide, make the unequivocal assignment of particular roles for the capsule more difficult. Possibly the best studied capsules of Gram-negative bacteria are the capsular polysacchdrides (or K-antigens) of Escherichiu coli. In part this is a reflection of our well-developed understanding of the genetics of E. coli and the ease of the application of the techniques of molecular biology.
More than 50 K-antigens have been described for E. coli (Orskov et al., 1977) . Virulent, extra-intestinal isolates of E. coli are encapsulated with particular K-antigens being associated with E. coli isolates from certain infections (Robbins et al., 1974; Kaijser et ul., 1977) . Encapsulated E. coli have 629th MEETING, LONDON increased resistance to complement-mediated killing and to phagocytosis and killing by PMNL (Gemski et al., 19 80; Kim et al., 1986; Allen et af., 1987) . In addition, certain K-antigens, such as the K1-antigen, a homopolymer of 2-%linked N-acetylneuraminic acid, are poorly immunogenic, being chemically related to carbohydrate moieties found on the mammalian cell surface (Schauer, 1981; Finne, 1982) . This molecular mimicry effectively means that as well as conferring some measure of resistance to the non-specific arms of the immune system, the presence of certain K-antigens may lead to the failure of the host to generate an adequate humoral response (Cross et al., 1983) .
Encapsulated E. coli are in general resistant to complement-mediated killing and, in the absence of specific antibodies, to complement-mediated opsonophagocytosis. Exposing encapsulated E. cofi isolates to human serum absorbed with isogenic unencapsulated E. cofi, followed by exposure to PMNL, results in little or no phagocytosis and killing (Horwitz & Silverstein, 1980) . However, addition of specific capsule antibodies to pre-absorbed serum results in classical pathway activation of complement on the capsule surface of E. coli and phagocytosis via Fc and C3b receptors on the PMNL surface. This indicates that the capsule is having a steric effect on complement fixation to the bacterial cell surface and masking structures such as LPS known to be capable of activating complement. However, the situation is likely to be much more complex than this, for instance it has been shown that antibodies to the somatic 0-antigen of certain encapsulated E. coli are protective (Kaijser & Olling, 1973) . In addition, opsonization of a serum-resistant E. coli 04:K12 strain with an anti-04 monoclonal antibody (Mab) is sufficient to induce phagocytosis and killing by PMNL (Abe et af., 1988) . However, the extent of phagocytosis and killing is enhanced when the bacteria are opsonized with an anti-K12 Mab or when both Mabs are used in conjunction (Abe et al., 1988) . Clearly, therefore, in this case sufficient LPS is exposed to allow specific opsonization and classical activation of complement followed by phagocytosis via Fc and C3b receptors. This may reflect the low level of encapsulation of this strain (Abe et al., 1988) . Therefore it is likely that the anti-phagocytic role of any particular K antigen may be dependent on the chemical structure and molecular arrangement of the polysaccharide and the overall topography of the particular bacterial cell surface.
Some information on the contribution of the E. coli K1-antigen to the virulence of E. coli has come from studies using the cloned genes encoding for synthesis (Boulnois & Roberts, 1989 ) of the K1 (Allen et al., 1987) and other antigens (F. K. Saunders, I. S. Roberts & G. J. Boulnois, unpublished work). The expression of the genes for the production of the K 1 -antigen in well-characterized laboratory strains of E. coli provides an opportunity to investigate the role that this capsule plays in resistance to complement killing and in the phagocytosis by PMNL. Laboratory strains of E. coli are rapidly killed by the bacteriocidal action of complement and are quickly phagocytosed and degraded within the PMNL. The presence of the cloned K1-genes in the laboratory strain conferred only a slight protection to the bacteriocidal activity of complement compared with the clinical K1 strain, indicating that a combination of cell surface structures in addition to the capsule may be important in this respect (Allen et al., 1987) . However, the presence of the K1 capsule on the surface of the laboratory strain did inhibit the rate of uptake of this strain by PMNL. The fact that these experiments were performed in the presence of heat-inactivated serum makes precise interpretation of the antiphagocytic role of the K1-antigen difficult in this case. It is possible the net negative charge imparted by the capsule may be exerting an effect. The presence of the K1-antigen on the surface of the laboratory strain of E. coli had no effect on the rate of killing and intraphagocytic degradation, in contrast to thc clinical K1 isolate which appeared highly resistant. Clearly these sorts of experiments are useful in attempting to dissect out a particular role for the capsule. However, the fact that many laboratory strains are deep, rough mutants lacking 0-antigen side-chains and part of the core of LPS, which in certain clinical strains have been implicated in resistance to phagocytic uptake (Rozenberg-Arska et al., 1985) , may well lead to conflicting results. Moreover, the correct assembly and maintenance of different components of the Gram-negative envelope may be mutually dependent, such that in laboratory strains expression of the cloned capsule functions results in an incomplete or aberrant capsule on the cell surface (Allen et d., 19 87) . Indeed, we have recently established that different recombinant plasmids encoding the same K-antigen confer different levels of serum resistance. This may reflect expression of differing amounts of the capsular polysaccharide in question. Previous studies have indicated in the case of E. coli K1 that the extent of polysaccharide production dramatically influences complement activation, opsonization and virulence (Bortolussi et al., 1979) .
In summary, the precise role the capsule plays in the virulence of Gram-negative organisms has been difficult to establish conclusively. Clearly it is important in conferring resistance to opsonophagocytosis, but the role other cell surface factors play in this process and the extent to which they might modulate capsule function awaits elucidation. [ 121. The final binding o f bacteria to the epithelial cells will thus depend both o n the expression of adhesins by the bacterial cell and o n the available receptors on the target cell.
The globoseries of glycolipid receptors for uropathogenic E. coli have rcccivcd spccial attention. They were the first group of receptor structures t o be identified. and the functional consequences of binding to these rcccptors have been extensively analysed.
Adherence erihuriiw hacwrinl p c 'rsi . ' . sttit ice When the adherence concept was first formulated. it was said that bacteria needed t o attach t o components of epithelial surfaces in order t o resist elimination by the flow of secretions [ 131. Bacterial persistence at mucosal surfaces has indeed been shown to be influenced by attachment to Gala 1 -4Gal/I-containing receptors. This is relevant at two sites: the large intestine and the urinary tract itself.
The large intestine serves as the ecological niche for Enterobacteriacae. Furthermore, it constitutes the reservoir for E. coli causing extraintestinal infections [ 141. The likelihood of causing such infections is related to the time of persistence. Strains which are resident in the large intestine have an increased chance to produce urinary tract infection [ 15,
161.
gTo whom correspondence should he addressed Abbreviations used: LPS. lipopolysaccharide; Determinants of persistence in the large intestine are likely to be numerous and of complex nature. We have investigated the presence in colonic mucosa of receptors for attaching E. coli [ 171. Colonic epithelial cells were obtained from two origins: colonic specimens from patients undergoing colorectal surgery and a colonic carcinoma cell line HT29. Bacteria with Gala 1 -4GalP specificity bound t o cells of both origins.
The role of attachment in persistence in the large intestine was analysed by correlating bacterial receptor specificity with the time of persistence as deduced from sequential faecal cultures from children with urinary tract infection. The strains with Gala 1 -4GalB specific adhesins persisted significantly longer than strains lacking such adhesins (A. Wold, G. Larsson & C. Svanborg Eden, unpublished work).
The role of attachment for bacterial persistence in the urinary tract has been studied in an experimental model for urinary tract infection [ 18, 191. E. coli strains were genetically manipulated to differ in the expression of Gala 1 -4GalB specific adhesins, but to retain other virulence factors. This was achieved in two ways: a deletion mutation in a fully virulent pyelonphritis strain eliminated the expression of adhesins. A non-virulent and non-adhering strain was transformed with the chromosomal DNA fragments encoding adherence factors. The ability of the virulent and transformant to persist in the urinary tract was compared with the adherent parent and the non-adhering recipient strain, respectively. By both procedures. it could be demonstrated that attachment enhanced bacterial persistence both in kidneys and bladders.
Role of adherence for iridiictiori ofirifluriimutiori
The injection of adherent E. coli strains into the mouse urinary tract results in a mucosal and systemic inflammatory response, which can be measured as the production of intcrleukins in urine and serum and as the recruitment of inflammatory cells to that site [20, 2 I] . This process was first shown to be dependent on the lipid A moiety of endotoxin [221. A high degree of inflammation did not occur in lipopolysaccharide (LPS) non-responder mice which are genetically incapable of reacting to lipid A. The adhesins, however, are required to anchor the bacteria on to the epithelial cells to present the toxin to the tissues. Adhesins synergistically increased the toxicity of lipid A, and blocking of adherence reduced the inflammation caused by whole bacteria [22] .
The ability of the adhesin-receptor interaction to activate inflammation independent of lipid A was analyscd by intravesical installation of isolated fimbriae with and without the adhesin. A significant response to the fimbriae occurred both in C3H/HeN (LPS responder) and C3H/HeJ (LPS nonresponder mice) ( Table 1) . These results represent the first evidence in vivo that the binding of a bacterial adhesin t o a glycoconjugate receptor initiates a signal in the target cell.
The inflammatory process has two components: an afferent phase during which interleukin 6 (IL-6) and other media-
